Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
International Paper
IP
$21.1B
| $3.17M | ﹤0.01% |
69,696
| – | – |
|
2802
CALL
Zebra Technologies
ZBRA
$17.1B
| $3.17M | ﹤0.01% |
45,500
-58,000
| -56% | -$3.57M |
|
2803
PUT
Jabil
JBL
$32.7B
| $3.16M | ﹤0.01% |
144,900
+11,100
| +8% | +$231K |
|
|
DHC
2804
Diversified Healthcare Trust
DHC
$1.9B
| $3.16M | ﹤0.01% |
+139,000
| New | +$3.08M |
|
2805
Assurant
AIZ
$14.1B
| $3.15M | ﹤0.01% |
34,198
-13,300
| -28% | -$1.16M |
|
2806
CALL
ProShares Ultra Energy
DIG
$79.8M
| $3.15M | ﹤0.01% |
65,600
-56,880
| -46% | -$2.61M |
|
|
WES
2807
PUT
DELISTED
Western Gas Partners Lp
WES
| $3.15M | ﹤0.01% |
57,200
+20,900
| +58% | +$1.05M |
|
|
ULQ
2808
DELISTED
CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF
ULQ
| $3.15M | ﹤0.01% |
62,713
+44,163
| +238% | +$2.22M |
|
2809
CALL
Cincinnati Financial
CINF
$26.5B
| $3.15M | ﹤0.01% |
41,700
+5,400
| +15% | +$409K |
|
2810
Estee Lauder
EL
$38.4B
| $3.14M | ﹤0.01% |
35,500
| – | – |
|
2811
PUT
Robert Half
RHI
$4.6B
| $3.14M | ﹤0.01% |
83,000
+50,600
| +156% | +$1.93M |
|
2812
PUT
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$257M
| $3.14M | ﹤0.01% |
700
+458
| +189% | +$1.74M |
|
2813
Molson Coors Class B
TAP
$7.77B
| $3.14M | ﹤0.01% |
28,558
+17,758
| +164% | +$1.8M |
|
2814
CALL
Stratasys
SSYS
$699M
| $3.13M | ﹤0.01% |
130,000
-86,600
| -40% | -$1.89M |
|
2815
CALL
EPAM Systems
EPAM
$5.82B
| $3.13M | ﹤0.01% |
45,100
+9,300
| +26% | +$632K |
|
2816
PUT
iShares S&P 500 Value ETF
IVE
$50.2B
| $3.12M | ﹤0.01% |
32,900
-27,900
| -46% | -$2.66M |
|
2817
H&R Block
HRB
$6.47B
| $3.12M | ﹤0.01% |
134,900
-44,606
| -25% | -$1.04M |
|
2818
PUT
Agilent Technologies
A
$44.5B
| $3.12M | ﹤0.01% |
66,300
-5,300
| -7% | -$247K |
|
|
HBI
2819
PUT
DELISTED
Hanesbrands
HBI
| $3.12M | ﹤0.01% |
123,400
-34,200
| -22% | -$901K |
|
2820
Black Hills Corp
BKH
$5.6B
| $3.11M | ﹤0.01% |
50,843
| – | – |
|
|
GIMO
2821
PUT
DELISTED
Gigamon Inc.
GIMO
| $3.11M | ﹤0.01% |
56,800
+25,600
| +82% | +$1.16M |
|
2822
Mid-America Apartment Communities
MAA
$14.9B
| $3.11M | ﹤0.01% |
+33,085
| New | +$3.3M |
|
2823
PUT
ProShares UltraPro Short S&P 500
SPXU
$384M
| $3.11M | ﹤0.01% |
336
-206
| -38% | -$1.95M |
|
2824
PUT
PACCAR
PCAR
$66.6B
| $3.11M | ﹤0.01% |
79,350
-13,500
| -15% | -$514K |
|
|
SNBR
2825
DELISTED
Sleep Number
SNBR
| $3.11M | ﹤0.01% |
143,907
-4,088
| -3% | -$101K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.